Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
NTRK2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GPATCH2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100507855 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMCO1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ABL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM20B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HGF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NOA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HDGF - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
METAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SDHC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CHRM3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RFC3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GALNT2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CACYBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TOR1AIP2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD50 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on